MOFFITT CANCER CENTER
LIVE

Serial Number

86214921

Owner

H. Lee Moffitt Cancer Center and Research Institute, Inc.

Attorney

Corey K. Cho

First Use Date

Nov 30, 2007

Filing Date

Mar 7, 2014

Add to watchlist:

No watchlists yet
View on USPTO

MOFFITT CANCER CENTER Trademark

Serial Number: 86214921 • Registration: 4640131

MOFFITT CANCER CENTER is a trademark filed by H. Lee Moffitt Cancer Center and Research Institute, Inc. on March 7, 2014. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

H. Lee Moffitt Cancer Center and Research Institute, Inc. (151 trademarks)

MRC-TTO
Tampa, FL 336129497

Entity Type: 99

Trademark Details

Filing Date

March 7, 2014

Registration Date

November 18, 2014

First Use Anywhere

November 30, 2007

First Use in Commerce

November 30, 2007

Published for Opposition

September 2, 2014

Goods & Services

Medical educational services, namely, conducting lectures, seminars and workshops to health care practitioners, patients and patient caregivers in the field of health care, cancer care and prevention of cancer, and medical diagnostics, prognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases

Publications, namely, printed instructional and teaching materials, brochures, pamphlets, bulletins, newsletters and magazines, all in the field of health care, cancer protection, prevention, detection and treatment, medical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases

Providing health care, medical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; medical services, namely, cancer care and prevention of cancer, and medical diagnostics, prognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counseling, namely, offering advice regarding cancer prevention, detection, treatment and clinical testing in the field of cancer and other diseases

Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicians, patients and researchers, namely, an online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, providing objective data in usable form on the effectiveness of a drug or diagnostic test

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 24, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 24, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 24, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 24, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 22, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 18, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 28, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 28, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 28, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 31, 2020 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 18, 2019 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 2, 2014 NPUB
PUBLISHED FOR OPPOSITION
Sep 2, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 13, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 26, 2014 PREV
ASSIGNED TO LIE
Jul 26, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 21, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jun 21, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jun 21, 2014 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2014 NWOS
NEW APPLICATION ENTERED
Mar 11, 2014 NWAP